Anamirta Cocculus Seed Ipecac Kerosene Strychnos N
| Evidence Level: L5 | Predicted Indications: 0 |
Table of Contents
- Anamirta Cocculus Seed Ipecac Kerosene Strychnos N
- ANAMIRTA COCCULUS SEED and Other Combination Formulas: Insufficient Assessment Data, Unable to Generate Predictive Report
ANAMIRTA COCCULUS SEED and Other Combination Formulas: Insufficient Assessment Data, Unable to Generate Predictive Report
One-Sentence Summary
This product is a five-component combination formula containing Anamirta Cocculus Seed, Ipecac, Kerosene, Strychnos Nux-Vomica Seed, and Tobacco Leaf, with unclear original indication data. The TxGNN model failed to generate any drug repurposing predictions, and this combination formula has no market authorization record in the United States; currently lacks fundamental data to support assessment.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | No data |
| Predicted New Indication | No prediction result |
| TxGNN Prediction Score | None |
| Evidence Level | L5 (Model failed to generate prediction, no actual research support) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
Currently, the TxGNN model failed to generate any drug repurposing prediction candidates for this combination formula, therefore a prediction reasonableness analysis cannot be performed.
This product consists of five components with the following component characteristics:
- Anamirta Cocculus Seed: Contains picrotoxin, a GABA receptor antagonist, historically used as fish poison and insecticide.
- Ipecac (Ipecac Root): Contains emetine, traditionally used as an emetic with cardiac toxicity.
- Kerosene: Petroleum derivative, organic solvent with no known therapeutic use.
- Strychnos Nux-Vomica Seed (Strychnine Seed): Contains strychnine and brucine, belong to highly toxic alkaloids, small amounts were found in traditional medicine, modern use not recommended.
- Tobacco Leaf (Tobacco Leaf): Contains nicotine, known to have multiple toxicological effects.
All components of this combination formula have significant toxicity, and most are of agricultural/traditional use rather than modern drug development targets. DrugBank has no corresponding ID, nor MOA data; this is the fundamental reason why the model cannot make predictions.
Clinical Trial Evidence
Currently no relevant clinical trials registered.
Literature Evidence
Currently no relevant literature data.
US Market Information
This combination formula has no NDA or market authorization records in the United States, unable to provide authorization information table.
Safety Considerations
All safety data for this product are missing, and the components themselves have known acute and chronic toxicity risks, strongly recommend:
- Must not conduct any human use assessment without obtaining complete toxicological evaluation
- Kerosene is an organic solvent, oral toxicity is clear, itself is a non-pharmaceutical component
- Strychnos Nux-Vomica contains strychnine, therapeutic index is extremely narrow, misuse can be fatal
- Anamirta Cocculus contains picrotoxin with central nervous system toxicity
- Ipecac is known to cause cardiomyopathy with prolonged use
Conclusion and Next Steps
Decision: Hold
Rationale: This combination formula has no TxGNN prediction results, no market records, no DrugBank registration, no safety data, and the component composition contains multiple known toxic substances (kerosene, strychnine, picrotoxin), does not meet the basic conditions to enter the drug repurposing evaluation process.
This case is not recommended to proceed further; if assessment is still needed, the following tasks must be completed first:
- Confirm whether this combination formula is indeed a drug to be evaluated (component combination is highly suspected to be agricultural/traditional use, not modern human medicine)
- If confirmed as a drug, obtain individual DrugBank registration and MOA data for each component
- Perform TxGNN prediction for each individual component separately, then evaluate combination formula interactions
- Complete toxicological data (acute toxicity, chronic toxicity, carcinogenicity) is a prerequisite for entering assessment
- Clarify whether Kerosene is an excipient or active ingredient, if it is an active ingredient, safety rationale must be provided
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.